NN 📈 NN - Overview
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0010773842
NN: Life Insurance, Non-Life Insurance, Banking, Reinsurance, Retirement Products
NN Group NV is a prominent financial services company that offers a comprehensive range of life and non-life insurance products to customers in the Netherlands and internationally. The company's operations are segmented into several key areas, including Netherlands Life, Netherlands Non-life, Insurance Europe, Japan Life, Banking, and Other segments, allowing for a diversified approach to the market. Through these segments, NN Group NV provides a broad spectrum of insurance products, including group and individual pension products, retail life insurance, and SME life insurance products, as well as non-life insurance products such as motor, fire, liability, transport, travel, health, property and casualty, and disability and accident insurance products.
The company's product offerings extend beyond insurance to include banking services, such as mortgage loans, bank annuities, consumer savings, and retail savings and investment products. Additionally, NN Group NV provides reinsurance services, which enable other insurance companies to manage their risk exposure, as well as retirement products and services designed to help individuals and organizations plan for the future. The company's distribution channels are multifaceted, allowing it to reach customers directly through tied agents, agents/brokers, platform insurance, and direct channels, thereby catering to the diverse needs of its client base, which includes individuals, small and medium-sized enterprises, and corporates.
With a history dating back to 1845, NN Group NV has a long-standing presence in the financial services industry. Formerly known as ING Insurance Topholding N.V., the company changed its name to NN Group NV in March 2014, marking a significant milestone in its evolution. Headquartered in The Hague, the Netherlands, NN Group NV is listed on the Euronext Amsterdam stock exchange under the ticker symbol NN, and its common stock is classified under the GICS Sub Industry: Life & Health Insurance, with the ISIN code NL0010773842. The company's website, https://www.nn-group.com, provides detailed information on its products, services, and activities.
Additional Sources for NN Stock
NN Stock Overview
| Market Cap in USD | 12,088m |
| Sector | Financial Services |
| Industry | Insurance - Diversified |
| GiC Sub-Industry | Life & Health Insurance |
| IPO / Inception |
NN Stock Ratings
| Growth 5y | 60.5% |
| Fundamental | 24.9% |
| Dividend | 79.7% |
| Rel. Strength Industry | -8.48 |
| Analysts | - |
| Fair Price Momentum | 43.53 EUR |
| Fair Price DCF | 8.98 EUR |
NN Dividends
| Dividend Yield 12m | 8.10% |
| Yield on Cost 5y | 14.16% |
| Annual Growth 5y | 7.79% |
| Payout Consistency | 97.2% |
NN Growth Ratios
| Growth Correlation 3m | -57.1% |
| Growth Correlation 12m | 87.3% |
| Growth Correlation 5y | 69.2% |
| CAGR 5y | 11.49% |
| CAGR/Mean DD 5y | 0.94 |
| Sharpe Ratio 12m | 1.01 |
| Alpha | 5.00 |
| Beta | 0.58 |
| Volatility | 19.76% |
| Current Volume | 1822.3k |
| Average Volume 20d | 913.2k |
As of December 21, 2024, the stock is trading at EUR 41.38 with a total of 1,822,265 shares traded.
Over the past week, the price has changed by -2.51%, over one month by -7.47%, over three months by -7.74% and over the past year by +26.25%.
Neither. Based on ValueRay Fundamental Analyses, NN is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NN as of December 2024 is 43.53. This means that NN is currently overvalued and has a potential downside of 5.2%.
NN has no consensus analysts rating.
According to ValueRays Forecast Model, NN NN will be worth about 47 in December 2025. The stock is currently trading at 41.38. This means that the stock has a potential upside of +13.61%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 51.3 | 23.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 47 | 13.6% |